ArticleInternational journal of chronic obstructive pulmonary disease2019

Pharmacokinetics and safety of revefenacin in subjects with impaired renal or hepatic function.

Marie T Borin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.